Drug intelligence / Profile preview

Arnica montana + Bellis perennis (homeopathic)

Development stage: Unknown
Lead developer: Shaare Zedek Medical Center
Administration: Oral

Overview

This homeopathic combination consists of highly diluted preparations of *Arnica montana* (Leopard's bane) and *Bellis perennis* (common daisy). It was evaluated in a clinical trial at Shaare Zedek Medical Center for its potential to reduce blood loss during the third stage of delivery (postpartum hemorrhage). In homeopathic tradition, these agents are used for their anti-hemorrhagic and analgesic properties following physical trauma. The clinical research compared two different potencies (C6 and C30) against a placebo to assess their impact on hemoglobin levels and overall blood loss in postpartum women.

Other names: Arnica montana C6Bellis perennis C6Arnica montana C30Bellis perennis C30

Targets

NFAT (NFAT family)NF-κB

Beyond the preview

Go deeper on Arnica montana + Bellis perennis (homeopathic).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arnica montana + Bellis perennis (homeopathic).

Explore the full profile